When is percutaneous nephrostomy (PCN) indicated instead of percutaneous nephrolithotomy (PCNL) for an obstructed or infected collecting system and renal stones larger than 2 cm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PCN vs PCNL for Obstructed/Infected Collecting System with Large Renal Stones

In patients with obstructed or infected collecting systems and renal stones larger than 2 cm, percutaneous nephrostomy (PCN) should be used for urgent drainage when infection is present, followed by delayed PCNL for definitive stone treatment once the infection is controlled. 1

Immediate Management: When PCN is Indicated

PCN is the urgent drainage procedure of choice in the following scenarios:

  • Active infection with obstruction (pyonephrosis): When infection is suspected in the face of ureteral or renal pelvic obstruction, the collecting system must be drained urgently with either a nephrostomy tube or ureteral stent to allow drainage of infected urine and antibiotic penetration into the affected renal unit 1. PCN may be preferred in pyonephrosis settings when larger tube decompression is warranted 2.

  • High-risk patients: PCN is the preferred option in patients at high risk for anesthesia, as it can be performed under local anesthesia with sedation 2.

  • Patient too ill for definitive treatment: Some patients may be too ill to undergo definitive stone treatment/removal at presentation 2.

Technical Considerations for PCN

  • Technical success rate approaches 100% for dilated collecting systems when performed with image guidance 2
  • Complication rates are low, typically around 6-10% 2
  • PCN provides 100% technical success compared to 80% for retrograde stenting in obstructed systems 2

Definitive Treatment: When PCNL is Indicated

For renal stones >20 mm, PCNL should be offered as first-line definitive therapy once infection is controlled 1:

  • PCNL offers stone-free rates of 74-83% for large stones 3
  • In a randomized trial comparing PCNL to URS for >2 cm renal pelvic stones, stone-free rate was 94% for PCNL versus 75% for URS 1
  • PCNL success is less dependent on stone composition, density, and location compared to other modalities 1

The Two-Stage Approach

A recent prospective randomized trial demonstrated that emergent PCNL (single-stage) is safe and effective compared to diverting PCN followed by delayed PCNL (two-stage) in obstructing ureteropelvic stone disease with sepsis 2:

  • Hospital stay: 8.18 ± 2.72 days for emergency PCNL group vs 10.09 ± 3.43 days for PCN group 2
  • No difference in complication rates or time to normalization of temperature, WBC count, and C-reactive protein levels 2

However, the traditional two-stage approach (PCN followed by delayed PCNL) remains appropriate when:

  • Patient is hemodynamically unstable or septic
  • Multiple comorbidities increase anesthetic risk
  • Coagulopathy that cannot be corrected urgently 1
  • Need for optimization of medical status before definitive surgery

Critical Pitfalls to Avoid

Do not attempt immediate PCNL in the following situations:

  • Untreated UTI or active sepsis: This is a contraindication to PCNL 4. Drain first with PCN, treat infection, then proceed with delayed PCNL.

  • Uncorrectable coagulopathy: Patients on anticoagulation or antiplatelet therapy that cannot be discontinued require careful monitoring and may need PCN as a temporizing measure 1, 4.

  • Prolonged manipulation during initial access: In infected systems, prolonged guidewire and catheter manipulation while obtaining access can lead to increased incidence of urosepsis 2. Limit manipulation during initial decompression.

Alternative Considerations

SWL should not be offered as first-line therapy for stones >20 mm 1:

  • Stone-free rates decline to only 10% for lower pole stones >20 mm with SWL 1
  • Significantly reduced stone-free rates and increased need for multiple treatments compared to PCNL 1

Retrograde ureteral stenting as an alternative to PCN:

  • May be associated with higher risk of urosepsis in some patients with extrinsic ureteral obstruction 2
  • Has been shown safe and effective with decreased hospital stay compared to PCN, though patients experience higher documented fever rates 2
  • Technical success only 80% compared to 100% for PCN in obstructed systems 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.